Monday, October 26, 2026

Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source document· December 29, 2025

Did Disney Win or Lose the OpenAI Deal?

View original at finance.yahoo.com

Did Disney Win or Lose the OpenAI Deal? In this podcast, Motley Fool contributors Travis Hoium, Dan Caplinger, and Jon Quast discuss: Disney's licensing deal with OpenAI…

Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

Deep concerns about lack of succession planning at Lululemon
80% confidence
Oracle could reach $80 billion annual revenue in approximately 2 years
80% confidence
Disney not in top 10 stocks to buy as of December 29, 2025
80% confidence
Mark Cuban regrets selling majority stake in Dallas Mavericks
80% confidence

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings

Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.

Our read on the data ›

Signals we're tracking

EPKINLY Regulatory-Clinical Success Cascade

High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

Patterns we're watching ›

Where sources disagree

Ford Motor Company

Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,994

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,994 facts checked against source5,500 source documents archived

Query this data → isubstrate.com

Did Disney Win or Lose the OpenAI Deal? — Source | Via News | ViaNews Market